163 related articles for article (PubMed ID: 11073087)
1. Regression of prostatic hypertrophy by osaterone acetate in dogs.
Tsutsu T; Hori T; Shimizu M; Orima H; Kawakami E; Fukuda S
J Vet Med Sci; 2000 Oct; 62(10):1115-9. PubMed ID: 11073087
[TBL] [Abstract][Full Text] [Related]
2. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E
J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183
[TBL] [Abstract][Full Text] [Related]
3. The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia.
Socha P; Zduńczyk S; Tobolski D; Janowski T
Pol J Vet Sci; 2018 Dec; 21(4):559-566. PubMed ID: 30605276
[TBL] [Abstract][Full Text] [Related]
4. Efficacies of osaterone and delmadinone in the treatment of benign prostatic hyperplasia in dogs.
Albouy M; Sanquer A; Maynard L; Eun HM
Vet Rec; 2008 Aug; 163(6):179-83. PubMed ID: 18689779
[TBL] [Abstract][Full Text] [Related]
5. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
6. Short-term oral treatment of canine benign prostatic hypertrophy with chlormadinone acetate.
Orima H; Shimizu M; Tsutsui T; Kawakami E; Ogasa A
J Vet Med Sci; 1995 Feb; 57(1):139-41. PubMed ID: 7538794
[TBL] [Abstract][Full Text] [Related]
7. Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
Kawakami E; Shimizu M; Orima H; Fujita M; Hori T; Tsutsui T
Int J Androl; 1998 Apr; 21(2):67-73. PubMed ID: 9675615
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Makanae Y; Yajima K; Ogasa A
J Vet Med Sci; 1993 Aug; 55(4):631-5. PubMed ID: 7691191
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the long-term effect of anti-androgen therapy by sonometrics in patients with benign prostatic hypertrophy].
Kimura A; Higuchi T
Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1697-702. PubMed ID: 2471862
[No Abstract] [Full Text] [Related]
10. DIAGNOSIS AND MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA IN A PIED TAMARIN (SAGUINUS BICOLOR).
Barbon AR; Ordóñez IA; Haworth P; Glendewar G; Routh A; Pocknell A
J Zoo Wildl Med; 2016 Jun; 47(2):609-13. PubMed ID: 27468035
[TBL] [Abstract][Full Text] [Related]
11. Prostatic fluid composition and semen quality in dogs with benign prostatic hyperplasia undergoing treatment with osaterone acetate.
Ferré-Dolcet L; Frigotto L; Contiero B; Bedin S; Romagnoli S
Reprod Domest Anim; 2022 Jan; 57(1):72-79. PubMed ID: 34706118
[TBL] [Abstract][Full Text] [Related]
12. [Clinical results and problems of anti-androgen therapy of benign prostatic hypertrophy].
Umeda K
Hinyokika Kiyo; 1991 Nov; 37(11):1429-33. PubMed ID: 1722628
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography].
Kazama T; Mizuno I; Takamine T; Umeda K; Terada T; Ishikawa S; Fuse H; Katayama T
Hinyokika Kiyo; 1990 Dec; 36(12):1423-7. PubMed ID: 1706136
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
15. Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
Takezawa Y; Ito K; Suzuki K; Fukabori Y; Yamanaka H; Honma S; Mieda M; Hamataki N; Kushitani M
Prostate; 1995 Dec; 27(6):321-8. PubMed ID: 7501544
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment for common prostatic conditions in dogs - benign prostatic hyperplasia and prostatitis: an update.
Niżański W; Levy X; Ochota M; Pasikowska J
Reprod Domest Anim; 2014 Jun; 49 Suppl 2():8-15. PubMed ID: 24947855
[TBL] [Abstract][Full Text] [Related]
17. Effect of chlormadinone acetate-pellet implantation on the volume of prostate, peripheral blood levels of sex hormones and semen quality in the dog.
Shimizu M; Tsutsui T; Kawakami E; Hori T; Fujita M; Orima H; Ogasa A
J Vet Med Sci; 1995 Jun; 57(3):395-9. PubMed ID: 7548388
[TBL] [Abstract][Full Text] [Related]
18. Effects of delmadinone acetate on pituitary-adrenal function, glucose tolerance and growth hormone in male dogs.
Court EA; Watson AD; Church DB; Emslie DR
Aust Vet J; 1998 Aug; 76(8):555-60. PubMed ID: 9741725
[TBL] [Abstract][Full Text] [Related]
19. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
Murakoshi M; Ikada R; Tagawa M; Nakayama T
Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
Katayama T; Umeda K; Kazama T
Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
